Therefore, our results suggest that LXR activation does not potentiate proinflammatory cytokine secretion (except for TNF-α) through the upregulation of TLR7 and TLR9 expression in patients with SLE. This evidence concerns the gene TLR9 and systemic lupus erythematosus.